Showing results (41-50 of 385) with videos related to

Sort By:
Pageof 39
Cancers|January 23, 2024
Carcinoma In Situ (CIS): Is There a Difference in Efficacy between Various BCG Strains? A Comprehensive Review of the LiteratureAndres Llano, Amy Chan, Cynthia Kuk, et al.
European Urology|July 12, 2014
Prevalence of inflammation and benign prostatic hyperplasia on autopsy in Asian and Caucasian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
The Canadian Journal of Urology|November 9, 2005
Remission of hormone-refractory prostate cancer attributed to EssiacWigdan Al-Sukhni, Ami Grunbaum, Neil Fleshner
European Urology|August 6, 2002
Repeat prostate biopsy: who, how and when?. a reviewBob Djavan, Mesut Remzi, Claude C Schulman, et al.
Journal of the National Cancer Institute|July 13, 2013
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian menAlexandre R Zlotta, Shin Egawa, Dmitry Pushkar, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
European Urology|June 20, 2003
Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centersAlexandre R Zlotta, Xenofon Giannakopoulos, Odd Maehlum, et al.
Urology Annals|October 7, 2011
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-GuérinSultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, et al.
Current Problems in Diagnostic Radiology|April 16, 2018
Comprehensive Imaging and Surgical Review of Urinary Diversions: What the Radiologist Needs to KnowArvind K Shergill, David C Wang, Seng Thipphavong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 4, 2013
Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: Incorporating new agents into clinical practiceAlan So, Joseph Chin, Neil Fleshner, et al.
Pageof 39